Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Recombinant CEACAM6 (Tinurilimab Biosimilar) antibody

The Human Monoclonal anti-CEACAM6 (Tinurilimab Biosimilar) antibody has been validated for ELISA, FACS, BLI, Func and SPR. It is suitable to detect CEACAM6 (Tinurilimab Biosimilar) in samples from Human.
Catalog No. ABIN7581328

Quick Overview for Recombinant CEACAM6 (Tinurilimab Biosimilar) antibody (ABIN7581328)

Target

CEACAM6 (Tinurilimab Biosimilar)

Antibody Type

Recombinant Antibody

Reactivity

Human

Host

  • 3
  • 1
Human

Clonality

  • 3
  • 1
Monoclonal

Conjugate

  • 3
  • 1
This CEACAM6 (Tinurilimab Biosimilar) antibody is un-conjugated

Application

ELISA, Flow Cytometry (FACS), Bio-Layer Interferometry (BLI), Functional Studies (Func), Surface Plasmon Resonance (SPR)
  • Expression System

    CHO Cells

    Purpose

    Anti-CEACAM6 / CD66c Reference Antibody (tinurilimab)

    Sequence

    QVTLRESGPA LVKPTQTLTL TCTFSGFSLS TYGIGVGWIR QPPGKALEWL AHIWWNDNKY YSTSLKTRLT ISKDTSKNQV VLTMTNMDPV DTATYYCARI SLPYFDYWGQ GTTLTVSSAS TKGPSVFPLA PCSRSTSEST AALGCLVKDY FPEPVTVSWN SGALTSGVHT FPAVLQSSGL YSLSSVVTVP SSNFGTQTYT CNVDHKPSNT KVDKTVERKC CVECPPCPAP PVAGPSVFLF PPKPKDTLMI SRTPEVTCVV VDVSHEDPEV QFNWYVDGVE VHNAKTKPRE EQFNSTFRVV SVLTVVHQDW LNGKEYKCKV SNKGLPAPIE KTISKTKGQP REPQVYTLPP SREEMTKNQV SLTCLVKGFY PSDIAVEWES NGQPENNYKT TPPMLDSDGS FFLYSKLTVD KSRWQQGNVF SCSVMHEALH NHYTQKSLSL SPG,DIQLTQSPSF LSASVGDRVT ITCKASQNVG TAVAWYQQKP GKAPKLLIYS ASNRYTGVPS RFSGSGSGTE FTLTISSLQP EDFATYYCQQ YSSYPLTFGG GTKVEIKRTV AAPSVFIFPP SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC

    Characteristics

    Anti-CEACAM6 / CD66c Reference Antibody (tinurilimab) is expressed from CHO. The heavy chain type is huIgG2, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.

    Purity

    >95 %

    Isotype

    IgG2SA
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Comment

    Therapeutic Agents by Target and Mechanism: CEACAM6 inhibitors

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Concentration

    1 mg/mL

    Buffer

    25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

    Storage

    4 °C,-80 °C

    Storage Comment

    +4°C,-80°C
  • Target

    CEACAM6 (Tinurilimab Biosimilar)

    Target Type

    Biosimilar

    Molecular Weight

    145.5 kDa

    UniProt

    P40199
You are here:
Chat with us!